Suppr超能文献

非ST段抬高型心肌梗死患者年龄增长与接受专科护理及长期死亡率的关联。

Association of increasing age with receipt of specialist care and long-term mortality in patients with non-ST elevation myocardial infarction.

作者信息

Zaman M Justin, Fleetcroft Robert, Bachmann Max, Sarev Toomas, Stirling Susan, Clark Allan, Myint Phyo Kyaw

机构信息

Medicine, James Paget University Hospital, Great Yarmouth, Norfolk NR31 6LA, UK Norwich Medical School, University of East Anglia, Norwich, Norfolk NR4 7TJ, UK.

Norwich Medical School, University of East Anglia, Norwich, Norfolk NR4 7TJ, UK.

出版信息

Age Ageing. 2016 Jan;45(1):96-103. doi: 10.1093/ageing/afv162. Epub 2015 Nov 24.

Abstract

BACKGROUND

observational studies suggest that older patients are less likely to receive secondary prevention medicines following acute coronary syndrome (ACS).

OBJECTIVES

to examine the association of increasing age with receipt of specialist care and influence of specialist care on long-term mortality in patients with non-ST elevation myocardial infarction (NSTEMI).

DESIGN

a cohort study.

SETTING

National ACS registry of England and Wales.

SUBJECTS

a total of 85,183 patients admitted with NSTEMI between 2006 and 2010.

METHODS

logistic regression analyses to assess receipt of secondary prevention medicines (ACE inhibitor, β-blocker, statin, aspirin) by age group; multivariate Cox regression models to examine longitudinal effect of cardiologist care on all-cause mortality by age group.

RESULTS

mean age 72.0 years (SD 13.0 years), mean follow-up was 2.13 years. Older patients received less cardiologist care (70.2% of NSTEMI patients ≥85 years compared with 94.7% of patients <65) years and had more co-morbidity. Cardiologists prescribed more secondary prevention in all age groups than generalists, but this was mostly explained away by co-morbidity (receipt of statin crude OR 1.51 (1.27,1.80), fully adjusted OR 1.11 (0.92,1.33) in patients ≥85 years). Receiving cardiologist care compared with generalist care was associated with a decreased risk of death in all even after adjustment for co-morbidity, disease severity and secondary prevention; this benefit reduced incrementally with older age group (adjusted hazard ratio (HR) 0.58 (0.49,0.68) aged <65; 0.87 (0.82,0.92) aged ≥85).

CONCLUSION

older patients with NSTEMI were less likely to see a cardiologist, but reduced treatment by generalists was explained away by co-morbidity. Cardiologist care was associated with lower mortality in all age groups than a generalist, but this survival benefit was less pronounced in older patients.

摘要

背景

观察性研究表明,老年患者在急性冠状动脉综合征(ACS)后接受二级预防药物治疗的可能性较小。

目的

研究年龄增长与接受专科护理之间的关联,以及专科护理对非ST段抬高型心肌梗死(NSTEMI)患者长期死亡率的影响。

设计

队列研究。

设置

英格兰和威尔士国家ACS登记处。

研究对象

2006年至2010年间共85183例因NSTEMI入院的患者。

方法

采用逻辑回归分析按年龄组评估二级预防药物(血管紧张素转换酶抑制剂、β受体阻滞剂、他汀类药物、阿司匹林)的使用情况;采用多变量Cox回归模型按年龄组研究心脏病专家护理对全因死亡率的纵向影响。

结果

平均年龄72.0岁(标准差13.0岁),平均随访2.13年。老年患者接受心脏病专家护理的比例较低(≥85岁的NSTEMI患者中有70.2%,而<65岁的患者中有94.7%),且合并症更多。在所有年龄组中,心脏病专家开出的二级预防药物比普通医生更多,但这在很大程度上被合并症所解释(≥85岁患者中他汀类药物的使用粗比值比为1.51(1.27,1.80),完全调整后的比值比为1.11(0.92,1.33))。与普通医生护理相比,接受心脏病专家护理与所有患者的死亡风险降低相关,即使在调整合并症、疾病严重程度和二级预防后也是如此;随着年龄组的增加,这种益处逐渐减少(调整后的危险比(HR):<65岁为0.58(0.49,0.68);≥85岁为0.87(0.82,0.92))。

结论

老年NSTEMI患者看心脏病专家的可能性较小,但普通医生治疗减少在很大程度上被合并症所解释。与普通医生相比,心脏病专家护理在所有年龄组中都与较低的死亡率相关,但这种生存益处在老年患者中不太明显。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验